Cachexia-a syndrome characterized by progressive muscle wasting-affects both humans and dogs with chronic diseases such as cancer.

Many people assume that some memory decline is an inevitable consequence of getting older. But a select group of older adults ...

The Food and Drug Administration (FDA) has granted Fast Track designation to remlifanserin for the treatment of hallucinations and delusions associated with Alzheimer disease psychosis (ADP).

A phenotype-based approach to CaHA use in facial rejuvenation treatments was associated with greater improvements across ...